Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionAvion Wealth
Latest Disclosed Ownership191 shares
Latest Disclosed Value $ 26
Avion Wealth reports 11.70% increase in ownership of GILD / Gilead Sciences, Inc.

On May 1, 2026 - Avion Wealth filed a 13F-HR form disclosing ownership of 191 shares of Gilead Sciences, Inc. (US:GILD) valued at $26,620 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 171 shares of Gilead Sciences, Inc.. The current value of the position is $24,637 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F GILEAD SCIENCES COM 375558103 191 20 11.70 0 0.0054
2026-01-23 2025-12-31 13F GILEAD SCIENCES COM 375558103 171 -3 -1.72 0 0.0042
2025-10-24 2025-09-30 13F GILEAD SCIENCES COM 375558103 174 -6 -3.33 0 0.0041
2025-07-31 2025-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 180 58 47.54 0 0.0043
2025-05-09 2025-03-31 13F GILEAD SCIENCES COM 375558103 122 0 0.00 0 0.0028
2025-01-29 2024-12-31 13F GILEAD SCIENCES COM 375558103 122 28 29.79 0 0.0028
2024-10-18 2024-09-30 13F GILEAD SCIENCES COM 375558103 94 59 168.57 0 0.0018
2024-07-26 2024-06-30 13F GILEAD SCIENCES COM 375558103 35 18 105.88 0 0.0006
2024-05-03 2024-03-31 13F GILEAD SCIENCES COM 375558103 17 -68 -80.00 0 0.0005
2024-01-26 2023-12-31 13F GILEAD SCIENCES COM 375558103 85 4 4.94 0 0.0020
2023-10-20 2023-09-30 13F GILEAD SCIENCES COM 375558103 81 -159 -66.25 0 0.0017
2023-07-14 2023-06-30 13F GILEAD SCIENCES COM 375558103 240 21 9.59 0 0.0047
2023-05-05 2023-03-31 13F GILEAD SCIENCES COM 375558103 219 16 7.88 0 0.0049
2023-01-30 2022-12-31 13F GILEAD SCIENCES COM 375558103 203 0 0.00 0 -100.00 0.0037
2022-10-31 2022-09-30 13F GILEAD SCIENCES COM 375558103 203 0 0.00 13 0.00 0.0040
2022-08-11 2022-06-30 13F GILEAD SCIENCES COM 375558103 203 0 0.00 13 8.33 0.0040
2022-05-04 2022-03-31 13F GILEAD SCIENCES COM 375558103 203 0 0.00 12 -20.00 0.0035
2022-01-26 2021-12-31 13F GILEAD SCIENCES COM 375558103 203 0 0.00 15 7.14 0.0042
2021-11-01 2021-09-30 13F GILEAD SCIENCES COM 375558103 203 200 6,666.67 14 0.0042
2021-07-27 2021-06-30 13F GILEAD SCIENCES COM 375558103 3 3 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.